Concourse Financial Group Securities, Inc. Amryt Pharma PLC Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

11 transactions

Quarter	Operation	Price Per share
Q1 2023 May 15, 2023	BUY	$7.0 - $14.77 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$6.68 - $7.58 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$6.8 - $8.01 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$6.85 - $8.87 $0 - $0
Q1 2022 May 09, 2022	BUY	$6.3 - $10.86 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$9.44 - $12.24 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$9.63 - $12.47 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$10.9 - $14.29 $0 - $0
Q1 2021 May 13, 2021	BUY	$13.04 - $14.75 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$12.22 - $14.16 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$10.8 - $13.5 $0 - $0

Others Institutions Holding AMYT

# of Institutions

Shares Held

142K

Call Options Held

Put Options Held

View Full List

About Amryt Pharma plc

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

More about AMYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account